NEW YORK — Alpenglow Biosciences has partnered with digital pathology lab PathNet to develop 3D pathology-based diagnostics for prostate and bladder cancers, the companies said on Thursday.

Alpenglow Biosciences, the leader in clinical-grade 3D digital pathology and AI-powered spatial analytics, and PathNet, one ...

Credit: Getty Images Investigators examined 5-year prostate cancer-specific mortality rates associated with 5 histologic subtypes, 4 of them rare. Compared with the dominant subtype, acinar ...

Men with less common types of prostate cancer have worse cancer control and greater need for radiation therapy after surgery. Oncologic and functional outcomes after robot-assisted radical ...

Cribriform prostate cancer is an aggressive subtype of the disease characterized by its histology, but little is known about its molecular pathways. Research from Vanderbilt-Ingram Cancer Center has ...

There is ongoing clinical need to improve estimates of disease outcome in prostate cancer. Machine learning (ML) approaches to pathologic diagnosis and prognosis are a promising and increasingly used ...

Ibex's high-performance AI platform--already deployed across more than 50 health systems worldwide and used in collaboration with major industry organizations such as Philips and Roche--now supports ...

Microscopic glands of the prostate are segmented (colored) with the new deep-learning pipeline; the image shows a prostate cancer tissue volume, measuring roughly 1 x 1 x 2 mm in size. The prostate ...

Prostate cancer remains a prevalent threat to men’s health, ranking second in cancer-related deaths in the United States. Each year, approximately 250,000 men in the U.S. receive a prostate cancer ...